Skip to main content
. Author manuscript; available in PMC: 2023 May 25.
Published in final edited form as: Circulation. 2023 Apr 17;147(21):1606–1621. doi: 10.1161/CIRCULATIONAHA.122.061940

Figure 8). Summary figure.

Figure 8)

Schematic depicting overall study findings from identification of RORα and HOXa5 as transcription factors binding PAH-associated variants in enhancers upstream of SOX17, through regulation of SOX17 by PAH stimuli, downstream effects of SOX17 on gene and protein expression profiles and endothelial cell behaviour, culminating in worsened PAH in SOX17-enhancer knockout mice.